New Vaccines for Chronic Respiratory Patients
-
Narmeen Mallah [4] ; Ana Dacosta Urbieta [4] ; Irene Rivero Calle [4] ; Francisco Javier Gonzalez Barcala [1] ; Tommaso Bigoni [2] ; Alberto Papi [3] ; Federico Martinón Torres [4]
-
[1] Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, España
-
[2] University of Ferrara
University of Ferrara
Ferrara, Italia
-
[3] Instituto de Investigación Sanitaria de Santiago de Compostela
Instituto de Investigación Sanitaria de Santiago de Compostela
Santiago de Compostela, España
-
[4] Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain
-
- Localización: Archivos de bronconeumología: Organo oficial de la Sociedad Española de Neumología y Cirugía Torácica SEPAR y la Asociación Latinoamericana de Tórax ( ALAT ), ISSN 0300-2896, Vol. 60, Nº. 9, 2024, págs. 565-575
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Chronic respiratory diseases (CRD) are responsible for more than four million deaths worldwide and have become especially prevalent in developed countries. Although the current therapies help manage daily symptoms and improve patients’ quality of life, there is a major need to prevent exacerbations triggered mainly by respiratory infections. Therefore, CRD patients are a prime target for vaccination against infectious agents. In the present manuscript we review the state of the art of available vaccines specifically indicated in patients with CRDs. In addition to pneumococcus, influenza, pertussis, and SARS-CoV-2 vaccines, recently added immunization options like vaccines and monoclonal antibodies against respiratory syncytial virus, are particularly interesting in CRD patients. As new products reach the market, health authorities must be agile in updating immunization recommendations and in the programming of the vaccination of vulnerable populations such as patients with CRDs. Organizational and educational strategies might prove useful to increase vaccine uptake by CRD patients.
